on Releaf Dispensary Ltd
Releaf and SOMAÍ Forge Exclusive UK Cannabis Partnership
Releaf, a leading UK medical cannabis clinic, has announced a strategic alliance with SOMAÍ Pharmaceuticals to enhance patient care in the UK. This partnership combines Releaf's strong supply chain capabilities with SOMAÍ's expertise in cannabis extracts, aiming to deliver high-quality treatments to patients across the nation.
The collaboration grants Releaf's clients exclusive access to SOMAÍ's comprehensive product lines, designed to address various patient needs with targeted THC/CBD ratios and terpene profiles. Additionally, Releaf assures a seamless treatment experience through its vertically integrated supply chain and Patient Charter.
Releaf aims to redefine the UK's medical cannabis sector, surpassing the current market size by expanding its patient base significantly. SOMAÍ supports this mission by providing an array of cannabis solutions to improve patient outcomes.
R. P.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Releaf Dispensary Ltd news